vs
自然阳光（NATR）与PREFORMED LINE PRODUCTS CO（PLPC）财务数据对比。点击上方公司名可切换其他公司
PREFORMED LINE PRODUCTS CO的季度营收约是自然阳光的1.4倍（$173.1M vs $123.8M），PREFORMED LINE PRODUCTS CO净利率更高（4.9% vs 3.3%，领先1.6%），自然阳光同比增速更快（4.7% vs 3.6%），PREFORMED LINE PRODUCTS CO自由现金流更多（$11.8M vs $7.6M），过去两年PREFORMED LINE PRODUCTS CO的营收复合增速更高（10.8% vs 5.6%）
自然阳光产品公司（简称NSP）主营膳食补充剂与个人护理产品的生产制造，产品涵盖草本补充剂、维生素、矿物质制剂等品类。公司总部设于犹他州利希，生产工厂位于犹他州西班牙福克，是该领域知名的健康产品生产商。
预成型线路产品公司（PLPC）研发、生产和销售适用于输配电、通信及可再生能源基建领域的工程硬件组件，服务全球多地的公用事业、网络运营商及工业客户，提供可提升网络可靠性与运营效率的解决方案。
NATR vs PLPC — 直观对比
营收规模更大
PLPC
是对方的1.4倍
$123.8M
营收增速更快
NATR
高出1.2%
3.6%
净利率更高
PLPC
高出1.6%
3.3%
自由现金流更多
PLPC
多$4.2M
$7.6M
两年增速更快
PLPC
近两年复合增速
5.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $123.8M | $173.1M |
| 净利润 | $4.1M | $8.4M |
| 毛利率 | 72.5% | 29.8% |
| 营业利润率 | 4.3% | 6.8% |
| 净利率 | 3.3% | 4.9% |
| 营收同比 | 4.7% | 3.6% |
| 净利润同比 | 1379.4% | -19.3% |
| 每股收益（稀释后） | $0.23 | $1.72 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NATRPLPC
| Q4 25 | $123.8M | $173.1M | ||
| Q3 25 | $128.3M | $178.1M | ||
| Q2 25 | $114.8M | $169.6M | ||
| Q1 25 | $113.2M | $148.5M | ||
| Q4 24 | $118.2M | $167.1M | ||
| Q3 24 | $114.6M | $147.0M | ||
| Q2 24 | $110.6M | $138.7M | ||
| Q1 24 | $111.0M | $140.9M |
净利润NATRPLPC
| Q4 25 | $4.1M | $8.4M | ||
| Q3 25 | $5.3M | $2.6M | ||
| Q2 25 | $5.3M | $12.7M | ||
| Q1 25 | $4.7M | $11.5M | ||
| Q4 24 | $-321.0K | $10.5M | ||
| Q3 24 | $4.3M | $7.7M | ||
| Q2 24 | $1.3M | $9.4M | ||
| Q1 24 | $2.3M | $9.6M |
毛利率NATRPLPC
| Q4 25 | 72.5% | 29.8% | ||
| Q3 25 | 73.3% | 29.7% | ||
| Q2 25 | 71.7% | 32.7% | ||
| Q1 25 | 72.1% | 32.8% | ||
| Q4 24 | 72.0% | 33.3% | ||
| Q3 24 | 71.3% | 31.1% | ||
| Q2 24 | 71.4% | 31.9% | ||
| Q1 24 | 71.2% | 31.3% |
营业利润率NATRPLPC
| Q4 25 | 4.3% | 6.8% | ||
| Q3 25 | 7.0% | 7.4% | ||
| Q2 25 | 3.7% | 10.1% | ||
| Q1 25 | 5.4% | 8.8% | ||
| Q4 24 | 3.8% | 10.5% | ||
| Q3 24 | 4.6% | 7.1% | ||
| Q2 24 | 5.1% | 8.1% | ||
| Q1 24 | 4.2% | 8.2% |
净利率NATRPLPC
| Q4 25 | 3.3% | 4.9% | ||
| Q3 25 | 4.2% | 1.5% | ||
| Q2 25 | 4.6% | 7.5% | ||
| Q1 25 | 4.2% | 7.8% | ||
| Q4 24 | -0.3% | 6.3% | ||
| Q3 24 | 3.8% | 5.2% | ||
| Q2 24 | 1.2% | 6.8% | ||
| Q1 24 | 2.1% | 6.8% |
每股收益（稀释后）NATRPLPC
| Q4 25 | $0.23 | $1.72 | ||
| Q3 25 | $0.30 | $0.53 | ||
| Q2 25 | $0.28 | $2.56 | ||
| Q1 25 | $0.25 | $2.33 | ||
| Q4 24 | $-0.02 | $2.13 | ||
| Q3 24 | $0.23 | $1.54 | ||
| Q2 24 | $0.07 | $1.89 | ||
| Q1 24 | $0.12 | $1.94 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $93.9M | — |
| 总债务越低越好 | — | $38.3M |
| 股东权益账面价值 | $161.6M | $475.5M |
| 总资产 | $261.1M | $653.6M |
| 负债/权益比越低杠杆越低 | — | 0.08× |
8季度趋势，按日历期对齐
现金及短期投资NATRPLPC
| Q4 25 | $93.9M | — | ||
| Q3 25 | $95.6M | — | ||
| Q2 25 | $81.3M | — | ||
| Q1 25 | $86.5M | — | ||
| Q4 24 | $84.7M | — | ||
| Q3 24 | $78.7M | — | ||
| Q2 24 | $68.7M | — | ||
| Q1 24 | $77.8M | — |
总债务NATRPLPC
| Q4 25 | — | $38.3M | ||
| Q3 25 | — | $36.0M | ||
| Q2 25 | — | $31.8M | ||
| Q1 25 | — | $29.1M | ||
| Q4 24 | — | $20.8M | ||
| Q3 24 | — | $27.2M | ||
| Q2 24 | — | $31.6M | ||
| Q1 24 | $2.1M | $55.0M |
股东权益NATRPLPC
| Q4 25 | $161.6M | $475.5M | ||
| Q3 25 | $166.7M | $466.3M | ||
| Q2 25 | $163.7M | $460.7M | ||
| Q1 25 | $167.1M | $435.8M | ||
| Q4 24 | $161.0M | $422.3M | ||
| Q3 24 | $162.6M | $429.0M | ||
| Q2 24 | $156.4M | $416.2M | ||
| Q1 24 | $159.7M | $413.4M |
总资产NATRPLPC
| Q4 25 | $261.1M | $653.6M | ||
| Q3 25 | $264.8M | $644.6M | ||
| Q2 25 | $254.9M | $631.5M | ||
| Q1 25 | $252.7M | $592.5M | ||
| Q4 24 | $240.9M | $573.9M | ||
| Q3 24 | $245.3M | $592.0M | ||
| Q2 24 | $235.8M | $572.6M | ||
| Q1 24 | $247.3M | $586.1M |
负债/权益比NATRPLPC
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | 0.08× | ||
| Q2 25 | — | 0.07× | ||
| Q1 25 | — | 0.07× | ||
| Q4 24 | — | 0.05× | ||
| Q3 24 | — | 0.06× | ||
| Q2 24 | — | 0.08× | ||
| Q1 24 | 0.01× | 0.13× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $9.9M | $21.9M |
| 自由现金流经营现金流 - 资本支出 | $7.6M | $11.8M |
| 自由现金流率自由现金流/营收 | 6.1% | 6.8% |
| 资本支出强度资本支出/营收 | 1.9% | 5.9% |
| 现金转化率经营现金流/净利润 | 2.41× | 2.60× |
| 过去12个月自由现金流最近4个季度 | $28.8M | $33.3M |
8季度趋势，按日历期对齐
经营现金流NATRPLPC
| Q4 25 | $9.9M | $21.9M | ||
| Q3 25 | $18.5M | $18.9M | ||
| Q2 25 | $4.3M | $26.9M | ||
| Q1 25 | $2.6M | $5.7M | ||
| Q4 24 | $12.2M | $24.1M | ||
| Q3 24 | $9.6M | $9.4M | ||
| Q2 24 | $1.3M | $28.3M | ||
| Q1 24 | $2.2M | $5.8M |
自由现金流NATRPLPC
| Q4 25 | $7.6M | $11.8M | ||
| Q3 25 | $16.8M | $8.3M | ||
| Q2 25 | $3.0M | $18.6M | ||
| Q1 25 | $1.5M | $-5.3M | ||
| Q4 24 | $10.0M | $20.6M | ||
| Q3 24 | $7.9M | $5.8M | ||
| Q2 24 | $-2.0M | $24.6M | ||
| Q1 24 | $-1.5M | $1.8M |
自由现金流率NATRPLPC
| Q4 25 | 6.1% | 6.8% | ||
| Q3 25 | 13.1% | 4.7% | ||
| Q2 25 | 2.6% | 10.9% | ||
| Q1 25 | 1.3% | -3.6% | ||
| Q4 24 | 8.5% | 12.3% | ||
| Q3 24 | 6.9% | 3.9% | ||
| Q2 24 | -1.9% | 17.7% | ||
| Q1 24 | -1.4% | 1.3% |
资本支出强度NATRPLPC
| Q4 25 | 1.9% | 5.9% | ||
| Q3 25 | 1.3% | 6.0% | ||
| Q2 25 | 1.2% | 4.9% | ||
| Q1 25 | 1.0% | 7.4% | ||
| Q4 24 | 1.9% | 2.1% | ||
| Q3 24 | 1.5% | 2.4% | ||
| Q2 24 | 3.0% | 2.7% | ||
| Q1 24 | 3.3% | 2.8% |
现金转化率NATRPLPC
| Q4 25 | 2.41× | 2.60× | ||
| Q3 25 | 3.46× | 7.21× | ||
| Q2 25 | 0.81× | 2.12× | ||
| Q1 25 | 0.55× | 0.49× | ||
| Q4 24 | — | 2.30× | ||
| Q3 24 | 2.21× | 1.22× | ||
| Q2 24 | 0.97× | 3.02× | ||
| Q1 24 | 0.94× | 0.60× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NATR
| Other | $68.1M | 55% |
| General Health Products | $20.2M | 16% |
| Digestive Products | $13.8M | 11% |
| Cardiovascular Products | $12.1M | 10% |
| Personal Care Products | $4.4M | 4% |
| Immunity Products | $3.1M | 3% |
| Weight Management Products | $2.1M | 2% |
PLPC
暂无分部数据
